ZA933669B - Removal of antibodies from blood-derived compositions while retaining coagulation factors - Google Patents
Removal of antibodies from blood-derived compositions while retaining coagulation factorsInfo
- Publication number
- ZA933669B ZA933669B ZA933669A ZA933669A ZA933669B ZA 933669 B ZA933669 B ZA 933669B ZA 933669 A ZA933669 A ZA 933669A ZA 933669 A ZA933669 A ZA 933669A ZA 933669 B ZA933669 B ZA 933669B
- Authority
- ZA
- South Africa
- Prior art keywords
- antibodies
- coagulation factors
- blood
- retaining
- removal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/265—Adsorption chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89052892A | 1992-05-28 | 1992-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA933669B true ZA933669B (en) | 1993-12-21 |
Family
ID=25396801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA933669A ZA933669B (en) | 1992-05-28 | 1993-05-26 | Removal of antibodies from blood-derived compositions while retaining coagulation factors |
Country Status (10)
Country | Link |
---|---|
US (1) | US5541294A (xx) |
EP (1) | EP0572194B1 (xx) |
JP (1) | JP3183750B2 (xx) |
KR (1) | KR100273010B1 (xx) |
AT (1) | ATE183098T1 (xx) |
AU (1) | AU667530B2 (xx) |
CA (1) | CA2096654C (xx) |
DE (1) | DE69325948T2 (xx) |
ES (1) | ES2137225T3 (xx) |
ZA (1) | ZA933669B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020182195A1 (en) * | 1997-08-05 | 2002-12-05 | Octapharma Ag | Universally applicable blood plasma |
EP0896824A1 (en) * | 1997-08-05 | 1999-02-17 | Octapharma Ag | A universally applicable blood plasma |
US6214221B1 (en) * | 1999-02-22 | 2001-04-10 | Henry B. Kopf | Method and apparatus for purification of biological substances |
NZ513242A (en) * | 1999-02-22 | 2003-10-31 | Henry B Kopf | Purification of biological substances |
EP1209969A2 (en) * | 1999-08-31 | 2002-06-05 | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. | Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders |
WO2001027623A2 (en) * | 1999-10-08 | 2001-04-19 | V.I. Technologies, Inc. | Isoagglutinin-depleted blood compositions and methods of making same |
US6646287B1 (en) * | 1999-11-19 | 2003-11-11 | Semiconductor Energy Laboratory Co., Ltd. | Semiconductor device with tapered gate and insulating film |
DE60133337T2 (de) * | 2000-02-08 | 2008-07-03 | Glycorex Transplantation Ab | Oligosaccharidenträger, beispielsweise für die entfernung von antikörpern aus dem blut |
DE10016877A1 (de) * | 2000-04-05 | 2001-10-18 | Scintec Diagnostics Gmbh Zug | (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung |
EP1272509A2 (en) * | 2000-04-05 | 2003-01-08 | V.I. Technologies, Inc. | Prion-binding peptidic ligands and methods of using same |
PT1696940E (pt) * | 2003-12-19 | 2007-05-31 | Octapharma Ag | Plasma sanguíneo aplicável universalmente, com inactivação de vírus, produzido de porções de plasma não-caucasiano. |
KR100791502B1 (ko) * | 2006-09-29 | 2008-01-03 | 한스바이오메드 주식회사 | 바이러스 불활화된 무세포 인체 이식재 생산방법 |
US8449520B2 (en) * | 2007-03-19 | 2013-05-28 | HemCon Medical Technologies Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US7776022B2 (en) * | 2007-03-19 | 2010-08-17 | Hemcon Medical Technologies | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090107001A1 (en) * | 2007-03-19 | 2009-04-30 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090223080A1 (en) * | 2007-03-19 | 2009-09-10 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
WO2012075041A2 (en) | 2010-11-29 | 2012-06-07 | New York Blood Center, Inc. | Method of blood pooling and storage |
FR3026950A1 (fr) | 2014-10-09 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de plasma universel |
FR3035799B1 (fr) | 2015-05-06 | 2017-05-05 | Elicityl | Support pour la purification de liquides biologiques |
FR3035794B1 (fr) | 2015-05-06 | 2017-05-05 | Elicityl | Procede pour la purification du sang total ou d'un produit issu du sang |
US10697982B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies |
US10697983B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies |
DE102020212609B3 (de) * | 2020-10-06 | 2022-04-07 | Universität Greifswald | Verfahren und Vorrichtung zur Herstellung von Universalplasma |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1544908A (en) * | 1975-07-08 | 1979-04-25 | Chembiomed Ltd | Artificial oligosaccharide antigenic determinants |
GB1603609A (en) * | 1977-04-14 | 1981-11-25 | Chembiomed Ltd | O-protected 2-azido-2-deoxy-glycosyl nitrates |
US4362720A (en) * | 1977-04-14 | 1982-12-07 | Chembiomed Ltd. | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals |
US4664913A (en) * | 1982-05-24 | 1987-05-12 | Xoma Corporation | Method for treating plasma for transfusion |
US4764369A (en) * | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
CH660634A5 (de) * | 1983-08-30 | 1987-05-15 | Dimitrios Giannitsis | Verfahren zur herstellung von natuerlichem immunoadsorbens. |
WO1986005397A1 (en) * | 1985-03-13 | 1986-09-25 | Nordisk Gentofte A/S | Immunosorbent for removal of rheumatoid factors from whole blood or blood plasma |
US5094960A (en) * | 1988-10-07 | 1992-03-10 | New York Blood Center, Inc. | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography |
US5149425A (en) * | 1988-11-09 | 1992-09-22 | Chembiomed, Ltd. | Affinity supports for hemoperfusion |
JP2926728B2 (ja) * | 1988-12-29 | 1999-07-28 | 吉富製薬株式会社 | 蛋白質含有組成物の製造方法 |
-
1993
- 1993-05-17 AU AU38647/93A patent/AU667530B2/en not_active Ceased
- 1993-05-19 CA CA002096654A patent/CA2096654C/en not_active Expired - Lifetime
- 1993-05-24 ES ES93303997T patent/ES2137225T3/es not_active Expired - Lifetime
- 1993-05-24 EP EP93303997A patent/EP0572194B1/en not_active Expired - Lifetime
- 1993-05-24 AT AT93303997T patent/ATE183098T1/de active
- 1993-05-24 DE DE69325948T patent/DE69325948T2/de not_active Expired - Lifetime
- 1993-05-26 ZA ZA933669A patent/ZA933669B/xx unknown
- 1993-05-28 JP JP12745993A patent/JP3183750B2/ja not_active Expired - Fee Related
- 1993-05-29 KR KR1019930009440A patent/KR100273010B1/ko not_active IP Right Cessation
-
1995
- 1995-04-11 US US08/419,836 patent/US5541294A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2096654A1 (en) | 1993-11-29 |
EP0572194B1 (en) | 1999-08-11 |
US5541294A (en) | 1996-07-30 |
AU3864793A (en) | 1993-12-02 |
KR100273010B1 (ko) | 2001-02-01 |
ATE183098T1 (de) | 1999-08-15 |
EP0572194A1 (en) | 1993-12-01 |
ES2137225T3 (es) | 1999-12-16 |
JPH06100463A (ja) | 1994-04-12 |
DE69325948D1 (de) | 1999-09-16 |
CA2096654C (en) | 2001-02-27 |
KR930023038A (ko) | 1993-12-18 |
DE69325948T2 (de) | 2000-01-20 |
JP3183750B2 (ja) | 2001-07-09 |
AU667530B2 (en) | 1996-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA933669B (en) | Removal of antibodies from blood-derived compositions while retaining coagulation factors | |
ATE35905T1 (de) | Verfahren zur herstellung keimfreier proteinmischungen. | |
ATE88097T1 (de) | Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut. | |
DE3887625D1 (de) | Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan. | |
CA2232604A1 (fr) | Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament | |
IL100253A0 (en) | Nitrogen derivatives | |
DE69004625D1 (de) | Verfahren zur Herstellung von strahlungsvernetzbaren Überzügen, strahlungsvernetzbare Zusammensetzungen und Carbonate. | |
DE69532137D1 (de) | Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen | |
DE3886845D1 (de) | Hochfeste, hitzebeständige Aluminiumlegierungen und Verfahren zur Herstellung von Gegenständen aus diesen Legierungen. | |
ATE17363T1 (de) | Verfahren zur herstellung von hochelastischen schaeumen und alkoxysilicium-verbindung(en) als schaumstabilisatoren hierfuer. | |
DE59409434D1 (de) | Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen | |
DE69009614D1 (de) | Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid. | |
DE59402292D1 (de) | Verfahren zur Herstellung von 1,3,5-Triazinen | |
DE69118002D1 (de) | Verfahren zur Herstellung von 1,1,1-Trifluorchlorethan und 1,1,1,2-Tetrafluorethan | |
JPS5738716A (en) | Incised wound treating composition | |
DE69300551D1 (de) | Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid. | |
DE69418364D1 (de) | Verfahren zur Herstellung von Polybutadienzusammensetzungen | |
DE59407675D1 (de) | Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on | |
DE69007245D1 (de) | Aminobutanolderivate und Verfahren zur Herstellung von 3-Pyrrolidinol aus diesen. | |
DE68917817D1 (de) | Verfahren zur Herstellung von vernetzten Polycarbonaten und Zusammensetzungen daraus. | |
EP1107789A4 (en) | COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUES AND CELLS FROM IMMUNE SYSTEM INDUCED LESIONS | |
DE59300777D1 (de) | Verfahren zur Herstellung von Perfluorpolyethern. | |
HUP0003610A1 (hu) | Eljárás biológiai anyag virális és molekuláris kórokozótartalmának gyérítésére | |
DE69934057D1 (de) | Verfahren zur Behandlung von Alkylamino (Meth)Acrylaten | |
DE69014501D1 (de) | Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück. |